AS

Astrana Health, Inc.

ASTHHealthcareNASDAQ

Medical Care Facilities · Last scanned Jul 18, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$3.18B
+56.4% YoY
Net Income
$22.5M
-47.9% YoY
EBITDA
$135.3M
-4.6% YoY
Free Cash Flow
$287.8M

Scan Results

Daily timeframe
6 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 RSI OverboughtRSI 75.6, above 70, stock may be overbought
Jul 10 RSI OverboughtRSI 77.1, above 70, stock may be overbought
About Astrana Health, Inc.

Part of the healthcare sector, Astrana Health, Inc. (ASTH) is listed under Medical Care Facilities. With a market capitalization of $2.23B, it sits in mid-cap territory. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.

Key stats
Market Cap$2.23B
P/E (TTM)73.67
Fwd P/E13.14
EPS$0.61
Beta0.89
52W Change+98.4%
ROE5.7%
Analysis

Astrana Health, Inc. carries $1.07B in total debt against $478.4M in cash reserves — debt is roughly 2.2x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $287.8M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 5.7%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.6% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.14B (2022) to $3.18B (2025), reflecting a 178% increase over the period.

At over 50x earnings, ASTH carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ASTH.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms